格隆汇11月13日｜Adaptimmune Therapeutics(ADAP.US)盘前涨超19%，报0.94美元。消息上，公司将于美东时间11月13日盘后发布财报。机构预期公司2024Q3实现营收2048.89万美元，同比增加179.94%。(格隆汇)

海量资讯、精准解读，尽在新浪财经APP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.